Literature DB >> 11270787

Effect of diet on changes in small intestinal blood flow following intracolonic administration of indomethacin to rats.

C Yamamoto1, K Kawakubo, K Aoyagi, T Matsumoto, M Iida, S Ibayashi, T Kitazono, K Doi, K Kanamoto, M Fujishima.   

Abstract

Liquid diet (LD) is known to be protective against indomethacin-induced enteropathy, which is thought to be associated with ischemic change. We tested the hypothesis that the solid component of diet modulates small intestinal blood flow (SIBF) following indomethacin administration. In the first experiment, male Wistar rats were divided into 18-hr-fasted and normal diet groups. Indomethacin (20 mg/kg) or vehicle was administered intracolonically. SIBF was measured on both the mesenteric and antimesenteric sides of the intestine, using the hydrogen gas clearance method. In the second experiment, rats were given LD alone or LD with increasing concentration of soluble/insoluble fiber for seven days. The baseline SIBF was significantly higher in the groups with normal diet and LD with fiber than in the fasting and LD groups. Following indomethacin administration, SIBF gradually decreased in the groups with normal diet and LD with insoluble fiber, while neither liquid diet nor fasting reduced SIBF. There was no difference in SIBF between the mesenteric and antimesenteric sides of the intestine in any group. Our findings suggest that solid components of diet increase basal SIBF and decrease SIBF following indomethacin administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270787     DOI: 10.1023/a:1005529016641

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Role of the proteasome in rat indomethacin-induced gastropathy.

Authors:  S J Brand; Z Morise; S Tagerud; L Mazzola; D N Granger; M B Grisham
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

2.  Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent process.

Authors:  J L Wallace; C M Keenan; D N Granger
Journal:  Am J Physiol       Date:  1990-09

3.  Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.

Authors:  B K Reuter; N M Davies; J L Wallace
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

4.  Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat.

Authors:  A Anthony; R Sim; A P Dhillon; R E Pounder; A J Wakefield
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

5.  Influence of tactile stimulation of the rat gastric mucosa on blood flow and acid output.

Authors:  L Holm; A Jägare
Journal:  Am J Physiol       Date:  1993-08

6.  Prostaglandin synthesis inhibition and postprandial intestinal hyperemia.

Authors:  R H Gallavan; C C Chou
Journal:  Am J Physiol       Date:  1982-02

7.  Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics.

Authors:  H Satoh; P H Guth; M I Grossman
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

8.  Indomethacin produces gastric antral ulcers in the refed rat.

Authors:  H Satoh; I Inada; T Hirata; Y Maki
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

9.  Resistance of germfree rats to indomethacin-induced intestinal lesions.

Authors:  A Robert; T Asano
Journal:  Prostaglandins       Date:  1977-08

10.  An animal model of longitudinal ulcers in the small intestine induced by intracolonically administered indomethacin in rats.

Authors:  T Matsumoto; M Iida; S Nakamura; K Hizawa; F Kuroki; M Fujishima
Journal:  Gastroenterol Jpn       Date:  1993-02
View more
  1 in total

1.  Microcirculatory changes in experimental mesenteric longitudinal ulcers of the small intestine in rats.

Authors:  Kayoko Shimizu; Hideki Koga; Mitsuo Iida; Ken Haruma
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.